XtalPi Opens AI-Driven Drug Discovery Platform to China Pharmaceutical University Community

Recently, XtalPi has once again reached a significant collaboration with China Pharmaceutical University. Relying on XtalPi's self-developed capabilities and industrial application experience in AI technology within the pharmaceutical research field, the company will gradually open its self-developed AI drug discovery technology platform to all faculty and students across the university. The first phase of the software deployment has now been completed, and the drug patent intelligent analysis software, PatSight, is now fully operational. Going forward, both parties will implement customized technical deployments and access for more drug discovery scenarios such as molecular design and molecular efficacy evaluation. This collaboration follows the previous partnership between XtalPi and China Pharmaceutical University.Joint Research Center(Click the blue text to view the link)Another milestone-level collaboration following a previous one, XtalPi has broken through bottlenecks in multiple key stages of drug research and development using artificial intelligence and robotic experimental technologies. It is assisting in building intelligent and automated research and development infrastructure in basic scientific research fields, while jointly exploring an innovative model that integrates industry and education as well as science and education.

XtalPi's AI Drug Discovery Technology Platform Integrates Cutting-Edge Technologies Such as Quantum Physics, Artificial Intelligence, and Cloud Computing. In terms of drug molecule discovery algorithms, it is capable of exploring an ultra-large druggable space for targets and designing and screening various drug properties. Through this technology platform, researchers can virtually screen compounds with higher key drug characteristics (such as non-toxicity, solubility, affinity, etc.) from a vast chemical space in less time and at lower cost, significantly improving R&D efficiency.

This collaboration provides unprecedented support for research and learning to all teachers and students of China Pharmaceutical University through the open use of the AI drug discovery technology platform.

In scientific research, teachers can use this platform to conduct more in-depth research on drug development-related topics and make breakthroughs in areas such as compound library synthesis, molecular building block synthesis, and reaction condition screening. In the past, many large-scale, high-precision experiments were difficult to carry out due to limitations in manpower and traditional technology. Now, with the help of this platform, research teams can design experiments and analyze data more efficiently, accelerating the output of scientific research results.

In terms of teaching, students have the opportunity to access cutting-edge intelligent R&D tools in the industry. By operating software hands-on, they can integrate pharmaceutical knowledge learned in the classroom with advanced artificial intelligence technologies, enhancing their professional competence and practical skills, thereby laying a solid foundation for future engagement in the field of intelligent pharmacy. Faculty and students at China Pharmaceutical University can now log in to XtalPi's AI Drug Discovery Technology Platform using their campus network accounts to experience the powerful functionalities of the first-phase AI toolkit, PatSight, and the MolValley module.

The deployment of XtalPi's AI drug discovery technology platform at China Pharmaceutical University marks a significant step in the university’s efforts to promote the development of intelligent pharmacy. The university will seize this opportunity to further strengthen in-depth cooperation with XtalPi in talent cultivation and scientific research, fostering interdisciplinary integration. This collaboration aims to nurture more versatile pharmaceutical talents suited to the needs of a new era and generate more innovative research outcomes, driving China’s pharmaceutical industry towards intelligent and highly efficient advancements.

XtalPi maintains close cooperation with universities in scientific research exchanges, the transformation of university achievements, and interdisciplinary talent cultivation. It explores innovative models of industry-education integration and the fusion of science and education. Leveraging its industrial experience and R&D achievements in the field of drug discovery, XtalPi promotes the cross-disciplinary integration of cutting-edge technologies such as artificial intelligence and robotic experimentation with fundamental disciplines like biology, physics, chemistry, and pharmaceutical sciences. This effort aims to enhance scientific research innovation capabilities and accelerate the upgrading and transformation of the pharmaceuticals industry. This groundbreaking collaboration with China Pharmaceutical University represents a new attempt in the field of intelligent pharmaceutical higher education. Through the continuous efforts of both parties, it is hoped that the deep application of advanced technologies in pharmaceutical disciplines will be further promoted, providing more referenceable experiences for the development of the intelligent pharmaceuticals field, and helping address global drug discovery challenges.